Abstract
Abstract
Objective
The Pharma Collaboration for Transparent Medical Information (phactMI™) benchmarking survey of 32 pharmaceutical companies describes the use of technology by Medical Information Departments.
Methods
A survey was distributed to phactMI™ member companies in June 2022 and included 79 closed and open-ended questions. The survey’s six sections included demographics, chatbot, social media, instant messaging applications, websites, and technology.
Results
Most Medical Information Departments have implemented innovative technology since 2019 with the main driver of remaining up-to-date. A total of 94% have a Medical Information website. Of those with a Medical Information website for healthcare professionals (HCPs), 97% allow for self-authentication. Most HCP-based websites have webforms for inquiries and 1–800 numbers, while only few offer video chat, chatbot, and the ability to identify local representatives. These websites also link to clinicaltrials.gov, publications, posters, and congress materials. Only 30% have a website for patients/caregivers. Most websites are discoverable by Google™. Awareness of Medical Information Websites occurs in a variety of ways, with most using multiple strategies to reach HCPs. There is wide variation in the technology platform used for the core functions of Medical Information.
Conclusion
As technology continues to advance and omnichannel content remains a key objective, Medical Information needs to remain agile and transformative in their strategic and tactical planning and execution. Based on this benchmarking survey, the authors recommend that Medical Information Departments focus on expanding services for patients/caregivers, leverage digital innovations, expanding awareness, building efficiencies in workflow through technology, and continually improving website functionalities with innovative technologies.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference7 articles.
1. Renu N. Technological advancements in the era of COVID-19. SAGE Open Med. 2021. https://doi.org/10.1177/20503121211000912.
2. Mobiquity Marketing. Digital transformation in pharma is reshaping the industry. 2023. www.mobiquity.com/insights/digital-transformation-pharma
3. Patel P, Gaspo R, Crisan A, et al. Where are we now in providing medical information in the digital space? A benchmark survey of PhactMITM member companies. Ther Innov Reg Sci. 2020;54:1282–90. https://doi.org/10.1007/s43441-020-00222-3.
4. Mohamed S, Dunnett S, Flores A, Loew E, Pienaar S, MILE (Medical Information Leaders in Europe). A Principles framework for digital provision of medical information for healthcare professionals. Pharmaceut Med. 2023;37(2):103–9. https://doi.org/10.1007/s40290-023-00464-0.
5. Evers M, Ghatak A, Holt E, et al. A vision for Medical Affairs in 2025. McKinsey & Company. 2019. https://www.mckinsey.com/industries/life-sciences/our-insights/a-vision-for-medical-affairs-in-2025